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ABSTRACT: The formation of the biomolecular corona represents a crucial factor in controlling the
biological interactions and trafficking of nanomaterials. In this context, the availability of key epitopes
exposed on the surface of the corona, and able to engage the biological machinery, is important to
define the biological fate of the material. While the full biomolecular corona composition can be
investigated by conventional bottom-up proteomics, the assessment of the spatial orientation of
proteins in the corona in a high-throughput fashion is still challenging. In this work, we show that
labeling corona proteins with isobaric tags in their native conditions and analyzing the MS/MS
spectra of tryptic peptides allow an easy and high-throughput assessment of the inner/outer
orientation of the corresponding proteins in the original corona. We put our results in the context of
what is currently known of the protein corona of graphene-based nanomaterials. Our conclusions are
in line with previous data and were confirmed by in silico calculations.
■ INTRODUCTION
The past 20 years have witnessed a steadily increasing research
interest in the use of nanomaterials for biological and
biomedical applications.1−3 Among nanomaterials, graphene-
based nanoflakes have shown interesting potentials for
biological applications,4−6 and several works have investigated
their properties in terms of interactions with proteins and
cells.7−13 In this context, the study of the biological
interactions occurring on the nanomaterial surface and their
engagement mechanisms with biological systems is of para-
mount importance to identify successful strategies for the
design of effective nanoformulations.14 It is well accepted that
the layer of biomolecules, mostly proteins, adsorbing on the
surface of nanomaterials, determines the final biological
identity of the nanomaterials once in contact with biological
fluids in vitro and in vivo (the so-called biomolecular or protein
corona).15−20 It has been shown that the biomolecular corona
can mask the nanoparticle-designed functionality, strongly
affecting the efficacy of the formulation and providing an
entirely new set of interacting moieties. The corona
composition, generally characterized through mass spectrom-
etry,21−23 is strictly related to several factors such as the core
material, the nanomaterial size and shape, the surface
chemistry, and the biofluid composition. However, only the
biomolecular domains that are exposed at the periphery of the
layer participate in the biological engagement with other
biomolecules, cell membranes, and cell receptors.21,24−26
Therefore, it is not sufficient to characterize the protein layer
in terms of mere composition, but it is of utmost importance to
identify how proteins preferentially orient their structure onto
the surface of the nanomaterial to identify key epitope domains
driving the bionano-interactions. To this aim, several recent
works have made use of immunometric mapping techniques
based on various types of reporters.27−31 These techniques
allow identifying the availability and functionality of specific
recognition sites by exploiting the affinity and specificity of
antibodies, and it is conceptually possible to multiplex the
mapping of antibody signal by using a plethora of different
reporters. However, the methodology still presents some
practical challenges, and complications arise when considering
that the biomolecular corona in situ is not a monolayer, and
proteins undergo dynamic exchanges in vivo.32 Zhang and
colleagues31 recently characterized the binding proteins
forming the total corona, suggesting that only a minor
percentage of proteins is able to bind its target. Based on
their findings, they proposed a multilayer corona structure,
focusing on the active sites of biological recognitions of the
external corona. These approaches, however, do not provide
information on the spatial orientation of the whole inner
protein structure (in contact with the material surface, the so-
called hard corona), an aspect that is commonly investigated in
silico.33,34 In this work, we propose a novel, complementary,
high-throughput methodology for the study of protein corona
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orientation. Graphene-based materials, due to their specific
affinity for proteins and large carrier capability, are emerging as
a novel class of biomedical nanomaterials for drug delivery,
sensing, and in vitro diagnostics.35−37 Given the involvement of
our group in the Graphene Flagship, we used two graphene-
based materials (with distinct surface chemistries) as models
for a proof-of-concept test of our approach. This approach
exploits isobaric labeling of proteins,38 followed by conven-
tional bottom-up proteomics, to derive information on the
spatial orientation of a given peptide directly from the list of
identified proteins. Other methods,39 while similar in the
general idea, do not allow easy and high-throughput
investigation or multiplexing. The results we obtained for the
protein corona of few-layer graphene (FLG, bare graphene
surface) and graphene oxide (GO), confirmed by in silico
analysis, suggested an intriguing connection between protein
preferential adsorption and orientation onto specific graphene-
based surface chemistries.
■ MATERIALS AND METHODS
Our work relies on a standard approach for bottom-up
proteomics investigation of protein corona performed by high-
resolution mass spectrometry. In short, the materials were
suspended in PBS and incubated with commercial human
plasma. Following the labeling at the protein level in native
conditions with the first tag, the corona was denatured and
labeled with the second tag, then digested with trypsin, and
analyzed. The only difference with conventional workflows for
corona proteomics is related to the labeling with isobaric tags
itself, which is performed following the protocol suggested by
the vendor. The full description of our experimental approach
is reported in the Supporting Information.
■ RESULTS AND DISCUSSION
We moved from previous works in the field of protein corona
orientation27,30 to figure out a high-throughput way to obtain
relevant information directly from conventional bottom-up
proteomics experiments used to identify the corona
composition. The idea is to employ well-established techniques
for protein isobaric labeling, widely used over the past 10 years
to quantify protein over- or underexpression in various
experimental conditions.40,41 Briefly, this approach uses
isotopically labeled tags to covalently label K residues and
N-terminal of tryptic peptides from different experimental
conditions, say A and B. While each tag is isotopically and
specifically labeled with the use of 15N and 13C atoms, the
overall mass of the tag is the same for all tryptic peptides
deriving from either A or B condition. In the bottom-up
proteomics experiments, both peptides elute simultaneously
from the chromatographic column and, having the same mass-
to-charge ratio (m/z), are selected together for the MS/MS
fragmentation. The fragment ions related to the primary
sequence of the peptides (allowing one to assign the peptide to
a given protein) are the same for both peptides. At the lower
end of the MS/MS spectrum, two distinct reporter ions, each
at a peculiar m/z ratio, are present. The relative intensities of
the reporter ions are directly related to the abundances of the
two peptides (and proteins) in the experimental groups. To
our purposes, we chose Thermo tandem mass tags (TMT)42 to
selectively label the “outer” and “inner” surfaces of the protein
corona. This approach holds the advantage to be independent
of the complex dynamics happening at the periphery of the
layer as it can identify the preferential orientation of a protein
onto a certain nanomaterial with given surface chemistry. To
maintain the spatial information, we labeled the corona at the
protein level rather than at the peptide level: therefore, labeling
occurs before digestion with trypsin, opposite to the usual
protocol. This procedure results in a generally slightly lower
number of positive protein identifications and a lower protein
sequence coverage and produces larger peptides as labeled K
residues are not recognized by trypsin, resulting in missed
cleavage sites. This alternative approach has also been widely
used in the past,43,44 including by our group for proteomics on
graphene oxide.7 It is important to point out that the
information on the orientation of the K residues of each
peptide positively assigned to a protein ID is automatically
calculated by any proteomics data analysis software and it is
retrieved directly from the list of identified proteins. The
orientation data thus come automatically, together with all
other conventional bottom-up proteomics results, making this
methodology suitable for high-throughput screening of nano-
materials. Figure 1 shows a general schematic of the
implemented isobaric labeling strategy in the corona
orientation workflow.
As a proof-of-concept study, two distinct materials, few-layer
graphene (FLG) and graphene oxide (GO), were incubated in
human plasma (HP) for 48 h to enrich the corona in proteins
having the highest affinities.36 The materials characterization is
reported in Figure S1. After washing the loosely attached
proteins with a series of centrifugal steps in phosphate-buffered
saline (PBS; see Materials and Methods), the exposed K
residues of the long-lasting corona under its native condition
were labeled with the 126 TMT tag (an isobaric tag that
produces a 126 m/z fragment ion in the MS/MS spectrum).
After removing the unreacted tag, the protein corona was
denatured using very harsh conditions (see Materials and
Methods). This treatment detached the corona from the
material, exposing the “inner” part of the corona that was then
labeled with the 127 TMT tag. After precipitation in cold
Figure 1. Diagram of the isobaric labeling workflow applied to the
investigation of protein orientation.
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acetone, the labeled proteome was digested with trypsin, and a
conventional LC−MS/MS protein identification experiment
was performed. As usual, peptides underwent MS/MS
experiments to match their backbone fragments against
suitable databases for protein identification. Only the peptides
carrying labeled K were selected as they were the ones showing
the two reporter fragment ions (126 and 127 m/z) in their
MS/MS spectrum. The relative intensity of these ions was
correlated to the preferential In/Out orientation of the
corresponding peptide in the native corona. The samples
were analyzed by LC−MS/MS, and all the obtained MS/MS
spectra were searched against the Homo sapiens protein
database. We first focused on protein identification, retaining
those protein-matching all the three replicates of each group.
We then compared the protein IDs from the two groups, as
reported in Figure 2 (left).
A total of 57 proteins were identified in both groups, while 4
and 66 were exclusively identified in the FLG and GO groups,
respectively (see Supporting File 1 for the complete list of
proteins). With gene enrichment analysis (Figure 2, right), we
highlighted the top 10 most significant biological pathways
differently represented by the proteins forming corona over the
two materials. Figures S2 and S3 show the corresponding most
enriched biological processes and molecular functions,
respectively. We then focused our attention on the 57 proteins
shared by the two materials, visually scrutinizing the peptides
assigned to each ID to determine the influence of the surface
chemistry on the protein preferential orientation. The full
peptide dataset is reported in Supporting File 2. We identified
46 peptides, assigned to 22 of the common proteins, observed
in both samples (FLG and GO) in all the three replicates. All
these peptides have K in their sequence and are thus carrying
information about their In/Out orientation. From a visual
Figure 2. Left: Venn diagram of the protein identified in the FLG and GO protein corona. Right: Gene enrichment analysis reporting the 10 most
significantly altered biological pathways enriched in FLG and GO protein corona.
Figure 3. Left: PCA analysis of the 46 peptide dataset. The two groups appear to be separated by unsupervised data analysis. Right: Heatmap
analysis of the In/Out orientation for the top 20 most significant peptides from a t-test comparison of FLG and GO corona. The In/Out ratios are
<1 for “cold” samples (blue) and >1 for “hot” samples (red).
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inspection (Supporting File 2), it is challenging to spot precise
trends in protein orientation: the same peptide almost always
shows opposite In/Out ratios in the three replicates, indicating
no preferential orientation of the corresponding protein on the
graphene material surface. Indeed, only 4 out of 46 peptides
(8%) showed concordant In/Out values in all the six samples.
With the aim to have a general overview of the whole dataset,
we then used principal component analysis (PCA) using the
observed In/Out ratios of the 46 peptides as variables. We then
performed t-test statistics for the two groups and a heatmap
analysis to highlight differential orientation trends. Figure 3
summarizes our findings.
The PCA shows that despite the highly complicated
appearance of the quantitative dataset, it is indeed possible
to observe patterns in the In/Out orientation of the 46
peptides, as also depicted in the heatmap analysis, which shows
orthogonality between the orientations on the two surfaces for
some of the proteins. For example, two of the three mapped
albumin pept ides (NECFLQHKDDNPNLPR and
VTKCCTESLVNR) appear to be oriented “In” when in
FLG corona (red values) and “Out” when in GO corona (blue
values). The third peptide (YTKKVPQVSTPTLVEVSR)
generated apparently random In/Out ratios, with blue and
red values mixed in the replicates. In this case, the covalent
labeling is capturing a nonspecific orientation of this part of the
sequence. This happens because that part of the sequence is
flexible enough to be dynamically moving on the corona
structure. Similar conclusions can be drawn for the APOE
peptide LSKELQ AAQAR and for the HPDEAAFFD-
TASTGKTFPGFFSPMLGEFVSETESR peptide of fibrinogen
alpha chain (FIBA). An opposite trend (“Out” for FLG and
“In” for GO) is observed for the DASGVTFTW
TPSSGKSAVQGPPER peptide of immunoglobulin heavy
constant alpha 1. Our method is, in this case, capturing kinetic
processes ongoing for parts of the sequences of corona
proteins. The observed trends in the In/Out ratios might thus
be associated with preferential orientations, or most likely
configurations, that these sequences assume in the corona.
Based on this assumption, we then hypothesized that proteins
showing high specificity for a given material might have a
specific affinity for its surface, therefore assuming more
univocally oriented conformation in the corresponding corona.
We then looked into the 4 and 66 proteins exclusively
observed in FLG or GO, respectively. We used the Venn
analysis of the peptides (Figure S4) to select those peptides
unique to each of the two materials. In the end, a list of 42
peptides was present in all three replicates of each group (the
details of the analysis are reported in Supporting File 2). The
proteins corresponding to these peptides present a more
specific orientation onto the surface of the two graphene
materials. Indeed, 19 out of 42 peptides (45%) show
concordant In/Out ratios in all three replicate samples. This
suggests a link between the protein affinity for given surface
chemistries and preferential orientation of the protein onto
that surface. Quite interestingly, all the concordant peptides
were observed in the GO group only, perhaps suggesting that
this material can induce a more defined orientation of the
specific proteins in its corona. Table 1 reports the summary of
these 17 concordant peptides (14 corresponding proteins).
To confirm our findings, we modeled the interaction of
some of these proteins with the GO surface by performing
docking simulations for proteins showing an In/Out peptide
ratio smaller than 1 and a known experimental structure. In
general, we observed a good agreement between the measured
In/Out ratio of the peptides and the predicted docked
orientation. Figure 4 reports the highest-ranking docked poses
of five proteins: carboxypeptidase N1 (CBPN), hemoglobin a
(HBA), immunoglobulin heavy variable 3-23 (HV323),
serotransferrin (TRFE), and ubiquitin 60S (RL40) on GO,
along with the average measured In/Out ratio of the
corresponding observed peptides (represented as yellow
spheres).
As expected from the experimental proteomics data, the
peptides with In/Out < 1 are mostly located on the periphery
of the protein, thus indicating that the preferential orientation
of specific proteins is efficiently “captured” by this labeling
strategy and proteomics workflow. When comparing the results
obtained with published proteomics data for FLG and GO,
some difficulties are expected, given the use of different
graphene-based materials (GRMs), experimental setups, and
Table 1. List of 17 Peptides Unique for GO, Having Concordant In/Out Ratios in All Three Replicatesa
In/Out ratio
protein peptide Rep1 Rep2 Rep3
APOA4 LTPYADEFKVKIDQTVEELR 0.51 0.55 0.66
LAKDSEKLKEEIGKELEELR 0.42 0.74 0.51
GNTEGLQKSLAELGGHLDQQVEEFRR 0.97 0.63 0.81
RVEPYGENFNKALVQQMEQLR 0.43 0.61 0.76
APOC2 DLYSKSTAAMSTYTGIFTDQVLSVLKGEE 0.16 0.41 0.35
CBPN IHILPSMNPDGYEVAAAQGPNKPGYLVGR 0.34 0.45 0.67
CO4A NVNFQKAINEKLGQYASPTAKR 0.62 0.72 0.93
CO5 GEQIQLKGTVYNYR 1.67 2.75 4.66
CXCL7 NLAKGKEESLDSDLYAELR 0.41 0.60 0.63
HBA VLSPADKTNVKAAWGKVGAHAGEYGAEALER 0.44 0.61 0.84
HV323 DNSKNTLYLQMNSLR 0.61 0.56 0.95
IBP3 EMEDTLNHLKFLNVLSPR 0.46 0.49 0.41
ITIH1 VQSWKGSLVQASEANLQAAQDFVR 1.58 1.29 1.84
KNG1 VQVVAGKKYFIDFVAR 0.28 0.26 0.49
LBP ITDKGLQYAAQEGLLALQSELLR 1.02 1.07 1.77
RL40 LIFAGKQLEDGR 0.41 0.91 0.90
TRFE NTYEKYLGEEYVKAVGNLR 0.36 0.60 0.67
aPeptides indicated in bold are highlighted in Figure 4.
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protein identification databases. We compared our results to
those of two recent publications on protein corona for bare
graphene nanoflakes in the human serum11 and GO in human
plasma.35 The extensive comparison of protein IDs of our
study with those reported in these two papers is reported in
Supporting File 3. We first noticed that despite the already
discussed limitations of protein-level labeling, the total
numbers of identified proteins in these studies (100 for the
work of Castagnola et al.11 and 153 for the work of Di Santo et
al.35) are only slightly higher compared to those found in this
study (61 for FLG and 123 for GO). While comparing our GO
data with the work of Di Santo et al. (Figure S5A), roughly
50% of the IDs match, indicating that our GO corona
composition is comparable. As far as FLG is concerned, the
comparison with the human serum protein corona from
Castagnola et al.11 (Figure S5B) indicates that 35% of the
corona proteins are shared by all three materials. GRM
materials are not standard nanomaterials used for proteomics
studies as they do not present a regular geometrical nanoshape,
and they are mostly a collection of “flakes” with different sizes
and shapes. Moreover, GRMs present diverse dispersion
stability in relation to their surface chemistry and hydro-
phobicity level. It is interesting to note that despite the
intrinsic complexity in handling these materials, a trend in the
preferential protein affinity for different GRM surfaces can be
extrapolated from data coming both from the present study
and other reports, even though the GRMs and biofluids
employed came from different sources (see Figure S6). Thirty-
one proteins are reported in Table 2, which are recurrent in the
protein corona of these four GRMs.
This comparison suggests that our orientation data obtained
with TMT experiments were generated on a protein corona
that is representative of what is currently known for other
GRMs. We also focused on the corona orientation data
reported by Castagnola et al.11 Based on a positive recognition
Figure 4. Docking of five proteins on GO. The corresponding peptide
is represented as yellow spheres, and the average In/Out ratio
measured by untargeted proteomics is indicated in red.
Table 2. Details of the 31 Proteins Observed in the Protein Corona of Four GRMs (Two from Our Study and Two from the
Literature)
entry name protein name gene name length
ALBU_HUMAN albumin ALB 609
APOA1_HUMAN apolipoprotein A-I (Apo-AI) (ApoA-I) (apolipoprotein A1) APOA1 267
APOE_HUMAN apolipoprotein E (Apo-E) APOE 317
VTNC_HUMAN vitronectin (VN) (S-protein) (serum-spreading factor) VTN 478
APOA4_HUMAN apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (apolipoprotein A4) APOA4 396
CO3_HUMAN complement C3 C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1 C3 CPAMD1 1663
HRG_HUMAN histidine-rich glycoprotein (histidine-proline-rich glycoprotein) (HPRG) HRG 525
CLUS_HUMAN clusterin (aging-associated gene 4 protein) (apolipoprotein J) (Apo-J) CLU APOJ CLI 449
IGJ_HUMAN immunoglobulin J chain (joining chain of multimeric IgA and IgM) JCHAIN IGCJ 159
GELS_HUMAN gelsolin (AGEL) (actin-depolymerizing factor) (ADF) (brevin) GSN 782
ITIH2_HUMAN inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) ITIH2 IGHEP2 946
SAA4_HUMAN serum amyloid A-4 protein (constitutively expressed serum amyloid A protein) SAA4 CSAA 130
A2MG_HUMAN alpha-2-macroglobulin (alpha-2-M) A2M CPAMD5 1474
KNG1_HUMAN kininogen-1 (alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) KNG1 BDK 644
ITIH4_HUMAN inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) ITIH4 IHRP 930
APOC4_HUMAN apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (apolipoprotein C4) APOC4 127
ITIH1_HUMAN inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) ITIH1 IGHEP1 911
FINC_HUMAN fibronectin (FN) (cold-insoluble globulin) (CIG) FN1 FN 2477
FETUA_HUMAN alpha-2-HS-glycoprotein (alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (fetuin-A) AHSG FETUA 367
APOB_HUMAN apolipoprotein B-100 (Apo B-100) [cleaved into: apolipoprotein B-48 (Apo B-48)] APOB 4563
CFAB_HUMAN complement factor B (EC 3.4.21.47) (C3/C5 convertase) CFB BF BFD 764
PLMN_HUMAN plasminogen (EC 3.4.21.7) [cleaved into: plasmin heavy chain A] PLG 810
TTHY_HUMAN transthyretin (ATTR) (prealbumin) (TBPA) TTR PALB 147
APOL1_HUMAN apolipoprotein L1 (apolipoprotein L) (Apo-L) (ApoL) (apolipoprotein L-I) (ApoL-I) APOL1 APOL 398
CO9_HUMAN complement component C9 C9 559
THRB_HUMAN prothrombin (EC 3.4.21.5) (coagulation factor II) F2 622
ANGT_HUMAN angiotensinogen (Serpin A8) AGT SERPINA8 485
CERU_HUMAN ceruloplasmin (EC 1.16.3.1) (ferroxidase) CP 1065
A1BG_HUMAN alpha-1B-glycoprotein (alpha-1-B glycoprotein) A1BG 495
C1S_HUMAN complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) C1S 688
AMBP_HUMAN protein AMBP [cleaved into: alpha-1-microglobulin (protein HC)] AMBP HCP 352
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of the corona proteins by an antibody targeting the 113−243
sequence of ApoA1, the authors show that this (large) part of
the protein (54% of the sequence) is exposed on the outer
surface of the corona. It is difficult to compare results from
such different techniques: the broad part of a protein
recognized by an antibody might be globally oriented outward,
while individual K residues present in its sequence might still
be facing the material. We nevertheless searched our
orientation data on ApoA1 for the corona of FLG, the closest
material to the graphene nanoflakes used in this paper. The
sequence (155−173) QKLHELQEKLSPLGEEMR shows an
apparently random orientation in our data, with an average In/
Out ratio of 1.1. The preceding peptide 108−140 QEMSK-
DLEEVKAKVQPYLDDFQKKWQEEMELYR, on the con-
trary, was not immediately present in our proteomics dataset.
This type of very large peptide (this one has a mass of 5325 Da
with the TMT tags) is not usually taken into consideration in
bottom-up proteomics experiments. We then manually
searched our RAW data, looking for MS and MS/MS data of
this individual peptide. Indeed, we found evidence of this
peptide (Figure S7A) as demonstrated by the presence of the
extracted ion current of its charge state 6+ ion at 887.98 m/z.
The mass spectrum (Figure S7B) shows that this peptide is
detectable as charge states 6+, 5+, and 4+. It is normally
difficult to obtain good MS/MS data from such large peptides,
but by dedicated experiments, we managed to confirm the
sequence of this molecule (Figure S8). Despite the presence of
five K residues in its sequence, each in principle having a
different orientation, we retrieved the data on its global In/Out
ratio that, in our experiments, was constantly <1 for the three
FLG replicates (Figure S9). This result supports the global
“outer” orientation of this part of ApoA1, and it is in
agreement with previous data.
■ CONCLUSIONS
This work represents a proof-of-concept study highlighting an
innovative strategy to simultaneously investigate the compo-
sition and the orientation of the proteins forming the
biomolecular corona onto nanomaterial surfaces. Our corona
composition data are in line with the current knowledge of the
protein corona of widely used GRMs (FLG and GO), and the
orientation data we obtained with the TMT tags match the
poses calculated by molecular docking. Our method allows us
to obtain data on protein orientation directly from large-scale
proteomics datasets, thus in a high-throughput way. In
addition to conventional bottom-up proteomics experiments
for protein corona, this approach is (1) fast (a few additional
hours of treatment are required), (2) easy to perform, (3)
relatively cheap, and (4) minimally invasive toward post-
translational modification analysis (several tens of phosphor-
ylation sites were identified in our data). Moreover, our
method can probe individual K residues, and it thus provides a
higher resolution compared to conventional immunometric
mapping, which normally relies on the antibody recognition of
large sequences of corona proteins. For a better understanding,
Table 3 gives a general overview and a comparison of the
advantages of our method compared to others currently
available.
The workflow we developed could be routinely imple-
mented into protein corona proteomics studies, and it would
represent a valuable tool in line with the great efforts for
nanomaterial biointeraction screening and classification
promoted by several EU nanosafety projects (Nanosolutions:
https://nanosolutionsfp7.com/, NanoREG I and II: http://
nanoreg2.eu/, Nanoclassifier: https://cordis.europa.eu/
project/id/324519/it, etc.). These efforts would greatly benefit
from easy-to-obtain information on the epitopes of corona
proteins that are exposed to biological interactions. Further-
more, our approach is multiplexable: TMT technology
(Thermo) allows us to label 2, 6, or 10 different conditions,
and ITRAQ (Sciex) allows 4 or 8 multiplexed experiments. In
this study, we used the TMT-6plex with the 126 and 127 tags.
All proteomics data analysis software allow us to easily handle
the plexing multiplicity, customize the reporting in many ways,
and retrieve different In/Out ratios directly from the protein
lists. This protocol opens up possibilities for analysis of
increasing complexity to get closer to the realistic in vivo
scenario. For example, different “layers” of corona proteins can
be analyzed in the same experiment by detaching treatments of
increasing strength followed by selective labeling with the
corresponding multiplexed tags. This might give an oppor-
tunity to investigate proteins that are more loosely bound to
the material surface and prone to dynamic exchange equilibria
with the solvent and the biological environment (so-called soft
corona).52 This investigation is currently performed with in situ
spectroscopic techniques,29,53−55 given the difficulty in tuning
the incubation/removal conditions to discriminate and isolate
the different corona layers, i.e., the outer layers of the corona,
loosely bound to the material. While our method can generate
orientation data with small additional effort compared to
routine proteomics experiments on protein corona, the
graphical representation of protein orientation will require
dedicated software solutions. Finally, to achieve the highest
sequence coverage (thus orientation data), overcoming the

















single-point determination of individual
epitopes
isobaric labeling *** *** *** *** YES YES * partiallyc
immunoAu27,28 * * ** * NO YES * YES
immunoQD29 * * * * NO YES *** YES
QCM30,45,46 * ** ** ** NO YES ** YES
FCS47,48 ** * * * NO NO *** NO
SANS49 * * * * NO NO *** NO
NMR50,51 *** ** ** * NO NO *** NO
aQCM, quartz crystal microbalance; FCS, fluorescence correlation spectroscopy; SANS, small-angle neutron scattering; NMR, nuclear magnetic
resonance spectroscopy. bCompared to conventional MS-based proteomics; allowing one to capture soft interactions. cOnly if K residues are in the
epitope.
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limitations of missed cleavages at K, multidimensional
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